Haemonetics (HAE) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -89.61% |
| Dec 27, 2025 | 22.06% |
| Sep 27, 2025 | 16.88% |
| Jun 28, 2025 | -16.35% |
| Mar 29, 2025 | -27.22% |
| Dec 28, 2024 | 15.93% |
| Sep 28, 2024 | 8.43% |
| Jun 29, 2024 | 52.02% |
| Mar 30, 2024 | -23.44% |
| Dec 30, 2023 | -28.53% |
| Sep 30, 2023 | 48.68% |
| Jul 1, 2023 | -25.98% |
| Apr 1, 2023 | 23.06% |
| Dec 31, 2022 | -19.72% |
| Oct 1, 2022 | -0.54% |
| Jul 2, 2022 | -26.76% |
| Apr 2, 2022 | 20.98% |
| Jan 1, 2022 | 51.52% |
| Oct 2, 2021 | -1.00% |
| Jul 3, 2021 | -50.72% |
| Apr 3, 2021 | -10.97% |
| Dec 26, 2020 | -81.78% |
| Sep 26, 2020 | 16.64% |
| Jun 27, 2020 | 37.26% |
| Mar 28, 2020 | -18.97% |
| Dec 28, 2019 | 45.20% |
| Sep 28, 2019 | -53.90% |
| Jun 29, 2019 | 19.09% |
| Mar 30, 2019 | -0.30% |
| Dec 29, 2018 | -34.61% |
| Sep 29, 2018 | 26.08% |
| Jun 30, 2018 | 25.71% |
| Mar 31, 2018 | -40.15% |
| Dec 30, 2017 | 51.85% |
| Sep 30, 2017 | 21.33% |
| Jul 1, 2017 | 32.62% |
| Apr 1, 2017 | -16.44% |
| Dec 31, 2016 | -18.53% |
| Oct 1, 2016 | 21.34% |
| Jul 2, 2016 | -30.06% |
| Apr 2, 2016 | -18.37% |
| Dec 26, 2015 | -37.55% |
| Sep 26, 2015 | -19.31% |
| Jun 27, 2015 | 3.36% |
| Mar 28, 2015 | 27.36% |
| Dec 27, 2014 | 21.49% |
| Sep 27, 2014 | -31.78% |
| Jun 28, 2014 | -38.70% |